Urinary Incontinence Market Research Report - Forecast To 2030

Urinary Incontinence Market information, by Types (Urge incontinence, Stress Incontinence, Overflow incontinence, Functional incontinence), Devices (Electrical Stimulation Devices, Foley Catheters, Antimicrobial Foley Catheters, Urethral Bulking Agents) - Forecast to 2030

ID: MRFR/MED/0591-HCR | February 2023 | Region: Global | 80 Pages         

Urinary incontinence Market Speak to Analyst Request a Free Sample

Urinary Incontinence Market

Urinary Incontinence Market is expected grow USD 17.43 Billion at a CAGR 6.3% during the forecast 2022 - 2030

By Type Urge incontinence Stress Incontinence Overflow incontinence Functional incontinence
By Devices Electrical Stimulation Devices Foley Catheters Antimicrobial Foley Catheters Urethral Bulking Agents
Key Players
Companies Profiled   NeoTract Inc   Promedon Cook Medical Inc.   R. Bard Inc.   Coloplast Corp   Boston Scientific Corporation   Ethicon US   LLC
Market Driving Forces   The Increasing prevalence of Urinary Incontinence   Development of innovative urinary catheters   Incontinence associated with chronic conditions
Request a Free Sample

Urinary Incontinence Market overview

The urinary incontinence market size is predicted to reach USD 17.43 billion by 2030 at 6.3% CAGR during the forecast period 2022-2030. Urinary Incontinence is a market that is gradually increasing and has a promising future. Urinary Incontinence (UI) is a medical ailment that causes a person to urinate involuntarily. It is also known as urine leaking when the person is not aware of it. Stress incontinence (leakage of urine due to pressure on bladder caused by sneezing, coughing, etc.), Urge incontinence (strong urge to urinate which leads to unconscious loss of urine), Overflow incontinence (constant dripping of urine due to bladder that does not completely empty or bladder incontinence) and Mixed incontinence are the different types of UI (patient suffering from more than one type of urinary incontinence). Physicians recommend distinct therapies based on the kind of incontinence.

Urinary incontinence is defined as an involuntary, uncontrollable flow of urine caused mostly by a lack of bladder control. Urinary incontinence can be caused by a variety of illnesses, including pregnancy, diabetes, delivery, menopause, and spinal or pelvic surgery. The increased prevalence of medical diseases associated with urine incontinence, as well as the growing elderly population, are important drivers driving urinary incontinence market expansion. According to the International Diabetes Federation, around half a billion people worldwide have diabetes, with the number expected to climb by 25% by 2030 and 51% by 2045. The increased number of diabetic individuals experiencing urinary issues is expected to propel the urinary incontinence treatment device market. Furthermore, the growing incidence of Parkinson's disease, new technology in urine incontinence, and the government's brisk effort to increase awareness about urine incontinence are all factors fueling the market. Unawareness of urinary urgency symptoms and post-surgery infections are two limitations that may stymie market expansion.

This report contains all the information on the urinary incontinence market overview, research, and market strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other important factors. And a detailed market analysis of urinary incontinence and forecast for 2030 is also included in the report.

Covid 19 Analysis

The expansion of Covid-19 has had an impact on industrial and building activity all over the world. Logistical constraints and rethinking raw material needs are becoming an issue for businesses. To rationalize production, companies have relied on derived demand as an intermediary commodity. The economic impact of the epidemic on businesses and financial markets is likewise negative. Stock market volatility and slowing global growth are expected to have an impact on the market.

Market Dynamic


The introduction of new urinary catheters, as well as an increase in demand for surgical treatment of urine incontinence to assure early cure, are major drivers driving the urinary incontinence market growth. Furthermore, the growing senior population, which typically suffers from urine incontinence or incontinence caused by chronic illnesses (kidney stones, miscarriages, paralysis, and neurological damage), drives market of urinary incontinence expansion.


Due to the enormous population base and low penetration of urinary incontinence devices in these economies, underdeveloped markets provide significant opportunities for the urinary incontinence therapeutics market.


Furthermore, increases in treatment rates and a susceptible aging population are two variables that influence the need for urinary incontinence medications. However, lack of knowledge of the disorders, as well as a preference for other therapy, are limiting factors in the urinary incontinence market growth. The industry is expected to be hampered by an increase in the number of incontinent patients who are unaware of their condition.


Growing healthcare reimbursement policies, disbursal income, and increased R&D investments are also expected to drive market expansion of urinary incontinence throughout the forecast period. However, the hazards related to urinary tract infections (UTI), invasiveness, and catheter care are the hurdles of the urinary incontinence devices industry. Furthermore, new market entrants and the advent of local market competitors with low-cost items pose a greater challenge.

Cumulative Growth Analysis

In February 2018, for example, research was conducted on the efficacy of Advantage Fit (mid-urethral sling) in the treatment of stress urinary incontinent individuals. From 2022 to 2030, the urge incontinence category is expected to increase at the quickest rate. Urinary incontinence medical devices are being developed expressly for the treatment of urge incontinence by key stakeholders. For example, in February 2018, Cogentix Medical, Inc. announced the commercialization of the Urgent PC Neuromodulation System (electrical stimulation device) for the treatment of urge incontinence.

Value Chain Analysis

According to the reports, the urinary incontinence market is segmented on the basis of types, devices, end-users, and regions. The maket of urinary incontinence is divided into types of incontinence, which include urge incontinence, stress incontinence, overflow incontinence, functional incontinence, and others. The stress incontinence category produced the most revenue among the aforementioned urinary incontinence types in 2016, and this trend is projected to continue throughout the projected period. The domination of stress urinary incontinence has been aided by an increase in research activity on the epidemiology of the condition. Electrical Stimulation Devices, Foley Catheters, Antimicrobial Foley Catheters, Urethral Bulking Agents, and Others are the devices segmentation that makes up the market.

The urinary incontinence market is segmented by product, with urinary catheters, vaginal slings, electrical stimulation devices, prosthetic urinary sphincters, and other devices accounting for the majority of sales. The section of urinary catheters is further subdivided into Foley catheters and other catheters. Vaginal slings, on the other hand, are divided into standard and advanced vaginal slings. The segment of vaginal slings earned the most revenue in 2016 and is likely to continue its dominance throughout the projection period.

Segmentation Overview

The market is segmented on the basis of types, devices, end-users, and regions. The market of urinary incontinence is expected to witness decent growth during the forecast period.

By Application

Based on the application, the urinary incontinence market is segmented into urge incontinence, stress incontinence, overflow incontinence, functional incontinence, and others.

 By End-Users

Based on the propulsion types, the urinary incontinence market is segmented into Electrical Stimulation Devices, Foley Catheters, Antimicrobial Foley Catheters, Urethral Bulking Agents, and Others.

Regional Analysis

According to the reports, the market of urinary incontinence is divided into four regions: North America, Europe, Asia-Pacific, and Latin America, and the Caribbean. North America led the market in 2016, accounting for the largest share, and this dominance is expected to continue throughout the projected period. The Asia-Pacific area, on the other hand, saw the strongest increase from 2017 to 2023. The urinary catheter market accounts for the bulk of the overall market value in the United States, Japan, and China. In all locations, the prevalence of urine incontinence rises with age. In this sense, the older population, paired with increased life expectancies, will boost the future market for urinary incontinence therapies. Urinary incontinence in the elderly can be caused by a number of reasons, including concomitant illnesses, drugs, neuro-urinary disease, and others. The urinary incontinence sling market in Europe accounted for the vast majority of overall market value. Female and male urine incontinence slings are available on the urinary incontinence sling market. Female urinary incontinence slings are further classified according to sling type. This market is shrinking as people become more aware of the dangers of female urinary incontinence slings.

Competitive landscape

Domestic firms are strengthening their market position of urinary incontinence by implementing methods such as research and development, mergers and acquisitions, and product launches.

Major Key Players

  • NeoTract, Inc

  • Promedon, Cook Medical Inc.

  • R. Bard Inc.

  • Coloplast Corp

  • Boston Scientific Corporation

  • Ethicon US

  • LLC

 Report Overview

The following urinary incontinence market report comprises of –

  • Market overview 

  • Covid 19 Analysis

  • Market Dynamic

  • Drivers

  • Opportunities

  • Restraints 

  • Challenges

  • Cumulative Growth Analysis

  • Value Chain Analysis

  • Segmentation Overview 

  • By Application 

  • By End-Users

  • Regional Analysis

  • Competitive landscape

Recent Developments

  • BladderCell will begin a bioelectric therapy clinical research for urine incontinence in November 2020.

  • Rigicon introduced two new artificial urinary sphincter types in May 2020: the ContiClassic Artificial Urinary Sphincter and the ContiReflex Artificial Urinary Sphincter.

Type Outlook (Revenue in USD Million; 2022–2030)

  • Total Incontinence

  • Overflow

  • Mixed

  • Stress

  • Urge

  • Functional

  • Others

Categories Outlook (Revenue in USD Million; 2022–2030)

  • External

  • Internal

End-Use Outlook (Revenue in USD Million; 2022–2030)

  • Ambulatory Surgical Centers

  • Clinics

  • Hospitals

  • Home Use

  • Others

Regional Outlook (Revenue in USD Million; 2022–2030)

North America

  • The U.S.

  • Canada


  • Germany

  • France

  • The U.K.

  • Spain

  • Italy

  • Rest of Europe

Asia Pacific

  • China

  • India

  • Japan

  • Rest of Asia Pacific

Latin America

  • Brazil

Middle East & Africa

Report Scope:

Report Attribute/Metric Details
  Market Size   USD 17.43 Billion
  CAGR   6.3%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Types, Devices, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   NeoTract, Inc, Promedon, Cook Medical Inc., C.R. Bard Inc., Coloplast Corp, Boston Scientific Corporation, Ethicon US, LLC and others
  Key Market Opportunities   Untapped economies offer profitable opportunities for the expansion of the market owing to the large population base
  Key Market Drivers

  • The Increasing prevalence of Urinary Incontinence
  • Development of innovative urinary catheters
  • Incontinence associated with chronic conditions

  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    urinary incontinence market is projected grow at approximately 6.3% CAGR during the assessment period (2022-2030).

    Promedon, NeoTract, Inc., Cook Medical Inc., Coloplast Corp, C.R. Bard Inc., Boston Scientific Corporation, and Ethicon US, LLC, are some of the major players operating in the urinary incontinence market.

    Based on types, the stress incontinence segment and based on devices, the Foley catheters segment hold larger shares in the urinary incontinence market.

    North America holds the largest share in the urinary incontinence market, followed by Europe and the Asia Pacific, respectively.